Preoperative chemotherapy with weekly docetaxel plus low-dose cisplatin and 5-fluorouracil for stage II/III squamous cell carcinoma of the esophagus

By Yoshida Takahiro  

Esophagus, Vol. 7, Iss. 2, 2010-06 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

Induction Chemotherapy with Docetaxel/Cisplatin/5-Fluorouracil for Patients with Node-Positive Esophageal Cancer

By  

Digestion, Vol. 83, Iss. 3, 2011-01 ,pp. : 146-152

Karger

Access to resources Recommend Favorite

Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma

By Kosugi Shin-Ichi   Kanda Tatsuo   Nakagawa Satoru   Ohashi Manabu   Nishimaki Tadashi   Hatakeyama Katsuyoshi  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 886-892

Informa Healthcare

Access to resources Recommend Favorite

Impact of extracapsular lymph node involvement on tumor progression in esophageal squamous cell carcinoma after neoadjuvant therapy and effects on lymph nodes induced by chemotherapy and chemoradiotherapy

By Saigusa Susumu   Mohri Yasuhiko   Tanaka Koji   Ohi Masaki   Shimura Tadanobu   Kitajima Takahito   Ishino Yoshito   Yasuda Hiromi   Okugawa Yoshinaga   Toiyama Yuji   Inoue Yasuhiro   Uchida Keiichi   Kusunoki Masato  

Esophagus, Vol. 11, Iss. 2, 2014-04 ,pp. : 108-116

Springer Publishing Company

Access to resources Recommend Favorite

Case series of preoperative triplet-regimen (docetaxel, CDDP and 5-fluorouracil) for borderline resectable T4 thoracic esophageal carcinoma

By Hamamoto Yasuo   Onodera Kei   Saito Mayuko   Akutsu Noriyuki   Inoue Koichi   Kobayashi Nozomu   Kuroki Yoshihito   Matsushita Naoyuki   Katano Susumu   Shimizu Hideaki  

Esophagus, Vol. 10, Iss. 4, 2013-12 ,pp. : 205-210

Springer Publishing Company

Access to resources Recommend Favorite